Pre-Market Stock News (November 27, 2007)

Investing

Published: November 27, 2007 8:14 am

Last Updated: March 26, 2020 12:36 pm

Below is a snapshot of much of the pre-market news moving individual stocks this morning:

Activision (ATVI) raised guidance on Guitar Hero III sales; stock up 8% pre-market.
Barrier Therapeutics (BTRX) announced positive results of higher dose escalation clinical safety study with pramiconazole.
Casual Male (CMRG) indicated lower after missing earnings and guiding lower.
CIGNA (CI) is acquiring Great-West Healthcare for $1.5 Billion.
Citigroup (C) sold a $7.5 Billion stake to Abu Dhabi Fund.
GlobalSantaFe (GSF) has received a subpoena from the SEC seeking documents related to the company’s ongoing internal investigation.
Hydrogenics (HYGS) received a $1.7 million order for three fuel cell hybrid MiniBuses for an Expo in Spain.
Osiris Therapeutics (OSIR) announced positive one-year data from Chondrogen trial for knee repair in its preparation of adult stem cells formulated for direct injection into the knee.
Penford Corp (PENX) announced a 2 Million share common stock offering, although this was under the existing shelf offering.
Pharmacopeia (PCOP) and GlaxoSmithKline identified two new additional lead compounds that will trigger milestone payment of $1 million to Pharmacopeia.
Qiao Xing (XING) telegraphss medium and long-term business plans and will continue to take steps to ensure growth of 20% to 30% per year for the next 5-years.
Sepracor (SEPR) announced the completion of its SEC investigation and no enforcement action was recommended.
Smith & Nephew (SNN) announces precautionary knee recall.
Staples (SPLS) $0.42 EPS vs $0.40 est.
Tech Data (TECD) $0.73 EPS vs $0.60 est. (unsure if comparable) sales guidance for Q4 looks a tad light.
Tenet Healthcare (THC) entered into a new national insurance coverage agreement with UnitedHealthcare (UNH).

Jon C. Ogg
November 27, 2007

Jon Ogg produces the 24/7 Wall St. Special Situation Investing Newsletter; he does not own securities in the companies he covers.

Credit Card Companies Are Doing Something Nuts

Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.

It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.

We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.